Published guidance, NICE advice and quality standards

Showing 581 to 590 of 754

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Omalizumab for previously treated chronic spontaneous urticaria	TA339	8 June 2015	8 June 2015
Vedolizumab for treating moderately to severely active ulcerative colitis	TA342	5 June 2015	5 June 2015
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism	TA341	4 June 2015	4 June 2015
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia	TA343	2 June 2015	2 June 2015
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome	TA335	25 March 2015	25 March 2015
Empagliflozin in combination therapy for treating type 2 diabetes	TA336	25 March 2015	25 March 2015
Rifaximin for preventing episodes of overt hepatic encephalopathy	TA337	25 March 2015	25 March 2015
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy	TA329	25 February 2015	25 February 2015
Sofosbuvir for treating chronic hepatitis C	TA330	25 February 2015	25 February 2015
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment	TA333	25 February 2015	25 February 2015